BEMER therapy is a consumer medical device that delivers low-intensity pulsed electromagnetic fields (PEMF) through a body mat, with the goal of temporarily increasing local blood circulation in healthy muscles. The device is FDA-cleared as a Class II powered muscle stimulator, not as a treatment for any disease. Sessions last about 8 minutes, and the system retails for around $4,590, making it one of the pricier wellness devices on the market.
How the Device Works
BEMER stands for Bio-Electro-Magnetic-Energy-Regulation. The system consists of a control box and a full-body mat (plus optional smaller applicators). During a session, you lie on the mat while it emits a very weak pulsed magnetic field at a frequency of 30 Hz. The magnetic field intensity maxes out at 35 microtesla, which is roughly a thousand times weaker than a refrigerator magnet. The device has 10 intensity levels you can adjust through the control box.
What makes BEMER distinct from other PEMF devices is a patented signal pattern (US Patent 8808159) that uses half-wave shaped sinusoidal intensity variations. The company calls this the “BEMER signal” and claims it specifically targets microcirculation, the flow of blood through your smallest blood vessels, including capillaries and arterioles.
What It Claims to Do in the Body
The central idea behind BEMER is that its electromagnetic signal stimulates vasomotion, which is the natural, rhythmic contraction and relaxation of tiny blood vessels. These micro-pumping movements help push blood through capillary beds where oxygen gets delivered to tissues and waste products like carbon dioxide get carried away. When vasomotion slows down, as it can with aging, inactivity, or certain health conditions, cells may not get adequate oxygen and nutrients.
BEMER’s proposed mechanism is that its specific pulse pattern nudges these small vessels back toward more active, rhythmic pumping. This would theoretically improve oxygen delivery to surrounding tissues and help clear metabolic waste. The company states the device “temporarily enhances local blood flow, resulting in better disbursement of oxygen within the target tissues while supporting the elimination of CO2.”
What the FDA Actually Cleared It For
The FDA cleared the BEMER Therapy System Evo as a Class II medical device under the category of “powered muscle stimulator.” This is an important distinction. The two specific cleared indications are narrow: temporarily increasing local blood circulation in healthy leg muscles, and stimulating healthy muscles to improve and facilitate muscle performance.
That clearance does not cover claims about treating chronic pain, healing wounds faster, improving sleep, boosting immune function, or addressing any medical condition. A 510(k) clearance also does not mean the FDA has confirmed the device works well. It means the device is substantially similar to other legally marketed devices in the same category and meets basic safety standards.
What the Research Shows
Published research on BEMER is limited and mostly small in scale. A preliminary study in patients with jaw and facial muscle pain found the device worth investigating further but did not establish it as a proven therapy. Another study looked at heart rate patterns in patients with coronary heart disease and noted that the BEMER signal could improve vasomotion and microcirculation, though the broader clinical significance of those changes remains unclear.
The honest picture is that there are no large, rigorous clinical trials demonstrating that BEMER produces meaningful, lasting health outcomes for any specific condition. The microcirculation effects that have been observed in smaller studies are real physiological measurements, but whether a temporary improvement in capillary blood flow during an 8-minute session translates into noticeable health benefits for the average person is not well established. Most of the glowing testimonials come from the company’s own marketing and its network of independent distributors.
What a Session Looks Like
A typical BEMER session involves lying on the body mat for 8 minutes. You select an intensity level on the control box (1 through 10), and the mat does the rest. You won’t feel much during the session. Some users report a mild warming sensation or tingling, but the magnetic field is so weak that many people feel nothing at all. The manufacturer suggests using the device once or twice daily.
The basic set, called the BEMER Basic-Set Evo, includes the control box (B.Box Evo), the full-body mat (B.Body Evo), a stand, and a power supply. It lists at $4,590. Smaller spot applicators for targeting specific body areas are sold separately. Some chiropractors, physical therapists, and wellness clinics offer individual BEMER sessions for a per-visit fee, which gives you a way to try it before committing to the full purchase price.
Safety and Contraindications
For most people, BEMER appears to carry minimal risk. The magnetic field it produces is extremely weak, and no serious widespread safety concerns have emerged in general use. That said, there are specific contraindications worth knowing about.
The manufacturer has issued warnings about using BEMER alongside insulin pumps. An FDA adverse event report documented a correction notice stating that “a causal link between the use of the BEMER therapy system and a technical defect in an insulin pump could not be ruled out with absolute certainty.” People using insulin pumps were told the device carries an absolute contraindication, meaning they should not use it at all. Other active medical implants, such as certain types of pacemakers or neurostimulators, may also be affected by electromagnetic fields, so anyone with an implanted electronic device should check with both the implant manufacturer and their doctor before using BEMER.
Organ transplant recipients and people on immunosuppressive therapy are also commonly listed as contraindicated groups for PEMF devices in general, though the specific evidence base for BEMER’s field strength causing problems in these populations is thin.
How It Compares to Other PEMF Devices
BEMER is far from the only PEMF device available. Competitors range from clinical-grade systems used in physical therapy offices to consumer mats that cost a fraction of BEMER’s price. What BEMER emphasizes as its differentiator is the patented signal waveform, which the company argues is uniquely effective at stimulating vasomotion. Other PEMF devices use different frequencies, intensities, and waveforms, and some operate at much stronger magnetic field strengths.
Whether BEMER’s specific signal pattern produces better outcomes than cheaper PEMF alternatives is not something independent research has conclusively answered. The patented waveform is a marketing distinction as much as a scientific one. If you’re considering PEMF therapy more broadly, comparing devices on the basis of published clinical evidence rather than patent claims will give you a clearer picture of what you’re paying for.
The Bottom Line on Value
At nearly $4,600, BEMER is a significant investment for a device with limited independent clinical evidence. It is a real, FDA-registered medical device, not a scam in the regulatory sense. But the gap between what the science currently supports (temporary, modest improvements in local blood flow during use) and what the marketing ecosystem around BEMER implies (broad wellness transformation) is wide. The people most likely to find value are those who have tried a session, noticed a subjective benefit, and can afford the cost without financial strain. For everyone else, the evidence does not yet justify the price tag.